Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01793519Phase 4Active, not recruiting
A Phase 4 trial of etanercept, infliximab, adalimumab in rheumatoid arthritis (RA), sponsored by Georgetown University. Started Jan 2013; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01793519.